In Europe, non-adherence to treatments cost 125,000 million per year


News of "Acta sanitaria" that references the report published  by the Pharmacy and Bioindustries Unit of Antares Consulting: "Economic impact of nonadherence in pharmaceutical costs"

Source:Acta Sanitaria
Access to the original news

Copyright © 2019 Antares Consulting S.L. All rights reserved   |   Legal information and Privacy policy